Home LiteratureArticle Details
PMID: 9520444 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.

Liang H, Fairman J, Claxton DF, Nowell PC, Green ED, Nagarajan L

Abstract

Complete or partial deletions of the long arm of chromosome 7 (7q- and -7) are nonrandom abnormalities seen in primary and therapy-induced myelodysplasia (MDS) and acute myelogenous leukemia (AML). Monosomy 7, occurring as the sole cytogenetic anomaly in a small but significant number of cases, may denote a dominant mechanism involving critical tumor suppressor gene(s). We have determined the extent of allele loss in cytogenetically prescreened MDS and AML patients for microsatellite markers from chromosome 7q22 and 7q31. Whereas >80% of these cases revealed allele loss for the entire region, a rare case of the 7q- chromosome showed allele loss for only the proximal 7q31.1 loci flanked by the markers D7S486 and D7S2456, and a case of monosomy 7 revealed allele loss for loci at both 7q31 and 7q22 with retention of sequences between these sets of loci. Furthermore, a case of AML with no cytogenetic anomaly of chromosome 7 revealed a submicroscopic allelic imbalance for a third distal locus, D7S677. These findings suggest the presence of three distinct critical loci that may contribute alone or in combination to the evolution of MDS and AML. The data also provide molecular evidence for unbalanced translocation with noncontiguous deletions, as an alternate mechanism underlying monosomy 7.

MeSH Terms
Chromosomes, Human, Pair 7 Gene Deletion Humans Leukemia, Myeloid, Acute/genetics Loss of Heterozygosity Myelodysplastic Syndromes/genetics
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Liang H
Department of Molecular Hematology and Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Fairman J
Claxton D F
Nowell P C
Green E D
Nagarajan L
References (33)
33 references, click to expand
  1. Childhood monosomy 7: epidemiology, biology, and mechanistic implications.
    Blood. 1995 Apr 15;85(8):1985-99 PMID: 7718870
  2. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.
    Cancer Res. 1995 Mar 15;55(6):1347-50 PMID: 7882334
  3. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
    Cancer Res. 1995 Sep 15;55(18):4114-9 PMID: 7664288
  4. Cytogenetic, molecular and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7.
    Mol Carcinog. 1996 Mar;15(3):167-75 PMID: 8597529
  5. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia.
    Blood. 1996 May 1;87(9):3579-86 PMID: 8611680
  6. Rarity of microsatellite alterations in acute myeloid leukaemia.
    Br J Cancer. 1996 Jul;74(2):255-7 PMID: 8688331
  7. Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias.
    Blood. 1996 Aug 1;88(3):1026-34 PMID: 8704211
  8. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
    Blood. 1996 Sep 15;88(6):1930-5 PMID: 8822909
  9. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
    Oncogene. 1996 Nov 7;13(9):2001-8 PMID: 8934547
  10. Development of a sensitive PCR to detect allele loss in a model hematopoietic neoplasm.
    PCR Methods Appl. 1994 Aug;4(1):6-12 PMID: 9018310
  11. Molecular delineation of the commonly deleted segment in mature B-cell lymphoid neoplasias with deletion of 7q.
    Genes Chromosomes Cancer. 1997 Feb;18(2):147-50 PMID: 9115965
  12. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
    Blood. 1997 Mar 15;89(6):2036-41 PMID: 9058725
  13. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.
    Anticancer Res. 1997 Jan-Feb;17(1A):93-8 PMID: 9066635
  14. Molecular cytogenetic characterization of del(7q) in two uterine leiomyoma-derived cell lines.
    Genes Chromosomes Cancer. 1997 Mar;18(3):155-61 PMID: 9071567
  15. Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
    Genes Chromosomes Cancer. 1997 Mar;18(3):193-9 PMID: 9071572
  16. Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer.
    Genes Chromosomes Cancer. 1997 May;19(1):1-5 PMID: 9135988
  17. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
    Nat Genet. 1997 May;16(1):68-73 PMID: 9140397
  18. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
    Oncogene. 1997 Jun 19;14(24):2979-84 PMID: 9205105
  19. A physical map of human chromosome 7: an integrated YAC contig map with average STS spacing of 79 kb.
    Genome Res. 1997 Jul;7(7):673-92 PMID: 9253597
  20. Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1.
    Exp Cell Res. 1997 Sep 15;235(2):345-53 PMID: 9299158
  21. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia.
    Leuk Res. 1987;11(2):119-33 PMID: 3469482
  22. Fragile sites induced by FUdR, caffeine, and aphidicolin. Their frequency, distribution, and analysis.
    Hum Genet. 1988 Jan;78(1):21-6 PMID: 2962925
  23. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Hematol Pathol. 1987;1(4):203-8 PMID: 3504436
  24. Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma.
    BMJ. 1991 Mar 30;302(6779):760-1 PMID: 2021766
  25. Quantitative acute leukemia cytogenetics.
    Genes Chromosomes Cancer. 1992 Jul;5(1):57-66 PMID: 1384663
  26. Comparison between interphase and metaphase cytogenetics in detecting chromosome 7 defects in hematological neoplasias.
    Am J Hematol. 1993 Jul;43(3):205-11 PMID: 8352237
  27. Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1.
    Mol Cell Biol. 1993 Oct;13(10):6036-43 PMID: 8105370
  28. 5q- chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts.
    Cancer Genet Cytogenet. 1994 May;74(1):8-12 PMID: 8194054
  29. Inhibition of tumorigenicity of a murine squamous cell carcinoma (SCC) cell line by a putative tumor suppressor gene on human chromosome 7.
    Oncogene. 1994 Oct;9(10):2817-25 PMID: 8084587
  30. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1.
    Cancer Res. 1994 Dec 15;54(24):6370-3 PMID: 7987830
  31. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.
    Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12155-8 PMID: 7991599
  32. A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression.
    Cancer Genet Cytogenet. 1994 Dec;78(2):181-8 PMID: 7828151
  33. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
    Oncogene. 1995 Jul 20;11(2):359-63 PMID: 7624150
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1998-03-31
Pages
3781-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC19914
Subset
IM
Grants
NCI NIH HHS · CA 55164 · United States
NCI NIH HHS · P30 CA016672 · United States
NCI NIH HHS · CA16672 · United States
NCI NIH HHS · CA 42232 · United States
NCI NIH HHS · P01 CA055164 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com